Diatheris is a company headquartered in Switzerland. Brouky records 1 investor associated with the company.
Diatheris is a biotech startup developing a therapeutic solution aimed at improving the management of type 1 diabetes. The company is categorized within pharma and biotech innovation supported by the FONGIT incubator.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.